The drug can now be prescribed alongside nab-paclitaxel for patients with ovarian cancer who have relapsed between one and ...
A technique that transforms immune cells into cancer-seeking bloodhounds may overcome a roadblock that has hampered ...
In a study of adults with advanced prostate cancer taking androgen-receptor pathway inhibitors and different types of ...
Almost four months ahead of schedule, Corcept Therapeutics' selective glucocorticoid receptor antagonist (SGRA) relacorilant ...
DelveInsight’s, “Hepatic Tumor Pipeline Insight 2026” report provides comprehensive insights about 75+ companies and ...
A new approach engineers immune cells to recognize byproducts of cancer cells to trigger migration toward the tumor.
India has tightened surveillance on GLP-1 weight-loss drugs to curb misuse, unauthorized sales, and unethical promotion. The ...
Intranasal oxytocin blocks the release of calcitonin gene-related peptide (CGRP) in animal models and is the core technology ...
First new FDA-approved treatment option in nearly 20 years for families living with this rare lysosomal storage diseaseFirst FDA-approved medicine in emerging new class of biotherapeutics that leverag ...
Rendering a drug effective or ineffective in a flash at the appropriate location – this is the focus of research in ...
Researchers are also studying whether they may lower the risk of certain serious illnesses, including some cancers. “GLP-1s ...
Researcher at Harvard Medical School develops AI-driven molecule targeting tumor mitochondria defects to destroy cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results